Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Gastrointestinal 3 Sarcoma 1 Gynecologic 1 CNS 1

Conditions

Meningioma 1 Hemorrhage 1

Interventions

Saline Solution 6 Dexmedetomidine 5 Sodium Chloride 4 Temozolomide 3 Sevoflurane 3 Propofol 3 Methotrexate 3 Levetiracetam 3 trametinib 2 perampanel 2 dabrafenib 2 Sugammadex 2 Neuroimaging 2 Methylphenidate 2 Magnetic Resonance Spectroscopy 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Gentamicins 2 Fluorescein 2 Anesthesia, Inhalation 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 pembrolizumab 1 pegvisomant 1 olutasidenib 1 naxitamab 1 lorlatinib 1 gadoterate meglumine 1 gadobenic acid 1 durvalumab 1 dexketoprofen trometamol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Tranexamic Acid × CNS × Clear all

NCT04386642 2021-01-27

Tranexamic Acid Reduce Blood Loss in Meningioma Resection

Chiang Mai University

Phase 4 Unknown

Hemorrhage, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡